LANGEPHARM ApS: Financial statements 2022
CVR: 25198956
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
LANGEPHARM ApS (CVR 25198956) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -8,468 and a net result of DKK -6,610 compared with DKK -9,353 the year before. Equity in the 2022 report amounted to DKK 823,059. The solvency ratio was 91.5%.
- Gross Profit
- DKK -8,468
- Profit/Loss
- DKK -6,610
- Equity
- DKK 823,059
- Total Assets
- DKK 899,279
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -8 t. | -7 t. | 823 t. | 0 |
| 2021 | - | -12 t. | -9 t. | 830 t. | 0 |
| 2020 | - | -33 t. | -26 t. | 839 t. | - |
| 2019 | - | 184 t. | 162 t. | 1.1 mio. | 0 |
| 2018 | - | 205 t. | 89 t. | 941 t. | 1 |
Official annual report
Keep an eye on LANGEPHARM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
LANGEPHARM ApS has published its annual report for 2021. Gross profit came to DKK -11,804, and the net result was DKK -9,353.
About LANGEPHARM ApS
LANGEPHARM ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company has been dissolved on 29 March 2023. The company was registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named SKIN CARE CONSULTING ApS. The company has 0 employees (2018). In 2022, the company reported a gross profit of DKK -8,468 and a net result of DKK -6,610 compared with DKK -9,353 the year before. Equity in the 2022 report amounted to DKK 823,059.